These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19656710)

  • 41. Transmission of a homogenous hepatitis B virus population of A1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult.
    Mphahlele MJ; Shattock AG; Boner W; Quinn J; McCormick PA; Carman WF
    Hepatology; 1997 Sep; 26(3):743-6. PubMed ID: 9303507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute sporadic hepatitis caused by the E virus in Chile. Clinical case].
    Ibarra H; Riedemann S; Froesner G; Reinhardt G; Toledo C
    Rev Med Chil; 1994 Jan; 122(1):68-71. PubMed ID: 8066347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute and chronic viral hepatitis.
    O'Connor JA
    Adolesc Med; 2000 Jun; 11(2):279-92. PubMed ID: 10916125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of hepatitis B, C, and E viruses and human immunodeficiency virus infections in Tahuna, Sangihe-Talaud Archipelago, Indonesia.
    Achwan WA; Muttaqin Z; Zakaria E; Depamede SA; Mulyanto ; Sumoharjo S; Tsuda F; Takahashi K; Abe N; Mishiro S
    Intervirology; 2007; 50(6):408-11. PubMed ID: 18185013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?
    Puoti M; Cozzi-Lepri A; Ancarani F; Bruno R; Ambu S; Ferraro T; Tundo P; Santantonio T; Toti M; Bonasso M; d'Arminio Monforte A; ;
    Antivir Ther; 2004 Oct; 9(5):811-7. PubMed ID: 15535419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term persistence of memory B cells specific for hepatitis B surface antigen in HIV-1-infected patients.
    Tuaillon E; Tabaa YA; Baillat V; Petitjean G; Reynes J; Vendrell JP
    AIDS; 2007 Nov; 21(17):2343-5. PubMed ID: 18090284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients].
    Rey D; Fritsch S; Schmitt C; Partisani M; Kempf-Durepaire G; Nicolle M; Krantz V; De Mautort E; Stoll-Keller F; Lang JM
    Gastroenterol Clin Biol; 2000 Jan; 24(1):125-7. PubMed ID: 10679599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection.
    Colson P; Dhiver C; Gérolami R
    Clin Microbiol Infect; 2008 Dec; 14(12):1176-80. PubMed ID: 19046170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses.
    Soriano V; Sheldon J; García-Gasco P; Vispo E
    AIDS; 2007 Oct; 21(16):2253-4. PubMed ID: 18090058
    [No Abstract]   [Full Text] [Related]  

  • 51. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    Bloquel B; Jeulin H; Burty C; Letranchant L; Rabaud C; Venard V
    J Med Virol; 2010 Feb; 82(2):206-12. PubMed ID: 20029819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Schnepf N; Sellier P; Bendenoun M; Zini JM; Sanson-le Pors MJ; Mazeron MC
    J Clin Virol; 2007 May; 39(1):48-50. PubMed ID: 17368969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute hepatitis B virus infection despite previous immunization in the context of recent HIV-1 infection.
    Emerson CR; Post JJ; Kelly MD
    AIDS; 2010 Aug; 24(13):2137-8. PubMed ID: 20679760
    [No Abstract]   [Full Text] [Related]  

  • 54. [Will a vaccine against hepatitis E soon be available?].
    Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2011 Jan; 40(1):44. PubMed ID: 21194081
    [No Abstract]   [Full Text] [Related]  

  • 55. Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E virus?
    Kuniholm MH; Labrique AB; Nelson KE
    Clin Infect Dis; 2010 Jun; 50(11):1545-6; author reply 1546. PubMed ID: 20433358
    [No Abstract]   [Full Text] [Related]  

  • 56. Persistent Viral Infections.
    Woodland DL
    Viral Immunol; 2016; 29(1):1. PubMed ID: 26669686
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute hepatitis E virus infection in human immunodeficiency virus-positive men and women in Nepal: Not quite a rare entity.
    Gupta BP; Shrestha A; Adhikari A; Lama TK; Sapkota B
    Hepatology; 2016 Sep; 64(3):1006-7. PubMed ID: 26845252
    [No Abstract]   [Full Text] [Related]  

  • 58. Severe thrombocytopenia associated with acute autochthonous hepatitis E.
    Fourquet E; Mansuy JM; Bureau C; Recher C; Vinel JP; Izopet J; Péron JM
    J Clin Virol; 2010 May; 48(1):73-4. PubMed ID: 20308017
    [No Abstract]   [Full Text] [Related]  

  • 59. New Models to Study Hepatitis E Virus Replication and Particular Characteristics of Infection: The Needle Hides in the Hay Stack.
    Debing Y; Schmid MA; Neyts J
    Gastroenterology; 2018 Jan; 154(1):20-22. PubMed ID: 29174543
    [No Abstract]   [Full Text] [Related]  

  • 60. [Severe genotype 4 acute autochthonous hepatitis E].
    Le Dault E; Luciano L; Surcouf C; Roque-Afonso AM; Coton T
    Presse Med; 2016; 45(7-8 Pt 1):705-6. PubMed ID: 27234901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.